Certara is pleased to announce the launch of the SimcypTM Discovery Simulator, a physiologically-based pharmacokinetic (PBPK) software developed specifically for discovery and translational scientists to increase confidence in decisions. Simcyp has been leading the scientific field of PBPK modeling for over twenty years and is used for decision-making throughout all stages of drug development and post-marketing.
While the benefits of the Simcyp Simulator are numerous and well-documented, we recognize that only a fraction of its extensive functionality is generally utilized during the initial phases of drug discovery and development. With this in mind, we are now proud to offer Simcyp Discovery. Its functionality has been tailored to address the needs of discovery and translational scientists.
If you would like to learn more about Simcyp Discovery Simulator, please register for a tour of the software and a live Q&A with our leading experts: Iain Gardner, PhD and Hannah Jones, PhD.
Key features of this new software include: